HRE Capital is pleased to announce the closing of the following transaction.
Sale / Leaseback of an Ambulatory Surgery Center and Medical Office Building Comprised of 29,906 Square Feet Located in Greater Memphis, Tennessee
The undersigned served as financial advisor
Healthcare Real Estate Capital (“HRE Capital”) was selected as the exclusive financial advisor to a private physician real estate ownership group (“Owner”) related to the sale / leaseback of an ambulatory surgery center and medical office building comprised of 29,906 square feet (“Assets”) located in Greater Memphis, Tennessee.
The transaction was structured as a long-term, sale / leaseback on an absolute net basis to OrthoSouth, a leading orthopedic focused practice with a market presence in Tennessee, Arkansas and Mississippi.
HRE Capital’s Role
On behalf of the Owner, HRE Capital undertook a selective effort to identify a well-capitalized investor (“Investor”) positioned to acquire the Assets in a particularly challenging capital markets environment and to execute a long-term lease agreement with OrthoSouth. Leveraging its unmatched relationships in the healthcare real estate capital markets, HRE Capital approached and garnered significant interest from a limited pool of active and well-capitalized investors. Due to HRE Capital’s successful track record with sale / leaseback transactions and the strength of the OrthoSouth, both the Owner and OrthoSouth achieved its respective goals related to pricing & overall transaction structure.
OrthoSouth offers world-class orthopedic care through its seven clinic locations & two ambulatory surgery centers across the Mid-South (Tennessee / Arkansas / Mississippi). The practice employs 35 physicians and 44 physical therapists and provides surgical & non-surgical treatment in general orthopedics and other subspecialties. OrthoSouth is the 27th largest orthopedic group in the United States, based on overall physician count.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE